Human Leukocyte Antigen–Haploidentical Transplantation for Relapsed/Refractory Hodgkin Lymphoma: A Multicenter Analysis-Reference-Cited by-同舟云学术

Human Leukocyte Antigen–Haploidentical Transplantation for Relapsed/Refractory Hodgkin Lymphoma: A Multicenter Analysis

Published:2017-04 Issue:4 Volume:23 Page:705-707
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Pitombeira de Lacerda Marcelo,Arrais Rodrigues Celso,Pereira André Domingues,Novis Yana,Fonseca Marina,Silva Roberto L.,Macedo Maria C.M.A.,Hamerschlak Nelson,Esteves Iracema,Schmidt Filho Jayr,Nascimento Marina M.,Rocha Vanderson

Funder

National Institute for Health Research (NIHR)

Oxford Biomedical Research Centre at Oxford University Hospitals NHS Trust and University of Oxford

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference9 articles.

1. Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma;Burroughs;Biol Blood Marrow Transplant,2008

2. Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability;Sarina;Blood,2010

3. Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!;Kharfan-Dabaja;Bone Marrow Transplant,2014

4. Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors;Kanate;Blood,2016

5. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability;Oncotarget;2023-12-12

2. Can we cure refractory Hodgkin’s lymphoma with transplantation?;Bone Marrow Transplantation;2020-07-07

3. Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment;Bone Marrow Transplantation;2019-08-21

4. Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2019-06

5. Haploidentical Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Aggressive Lymphomas: How Far Have We Come and Where Are We Going?;World Journal of Oncology;2019